Skip to content

Yap1 Mamld1 Fusion Positive Supratentorial Ependymoma C5670480

Published: July 22, 2026Updated: August 27, 2026

A rare brain tumor occurring in the upper part of the brain, driven by a specific genetic fusion. It primarily affects children. Treatment typically involves surgery and radiation therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Headache

!

Focal motor weakness

!

Visual field deficits

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Seizures

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Maximal Safe Surgical Resection

Microsurgical tumor resection performed by experienced neurosurgeons with goal of maximal safe resection while preserving neurological function. Extent of resection is strongly correlated with progression-free survival.

surgical
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Adjuvant Radiation Therapy

Focal conformal radiation therapy to the tumor bed and any residual disease, typically administered at doses of 54-60 Gy. May include proton beam therapy for pediatric patients to reduce long-term effects.

procedure

Additional treatment options

Adjuvant Chemotherapy

Systemic chemotherapy, typically platinum-based regimens, administered either concurrently with radiation or sequentially for higher-risk disease. May include temozolomide or other agents based on molecular tumor characteristics.

medication

Serial MRI Surveillance

Regular magnetic resonance imaging at defined intervals to detect early recurrence, typically every 3 months initially, then extending to every 6 months and annually based on stability.

monitoring

Rehabilitation and Functional Recovery

Comprehensive neurorehabilitation including physical, occupational, and speech therapy as needed based on tumor location and treatment effects. Focuses on recovery of motor function, cognitive rehabilitation, and return to daily activities.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Yap1 Mamld1 Fusion Positive Supratentorial Ependymoma C5670480?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Pajtler KW, Witt H, Sill M, et al. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. Cancer Cell. 2015.

review2015
2

Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021.

guideline2021
3

Parker M, Mohankumar KM, Punchline C, et al. C11orf95-RELA fusions drive oncogenic NF-kappaB signaling in ependymoma. Nature. 2014.

other2014
4

RuppNJ, Campos B, Weyerbacher JC, et al. Supratentorial Ependymoma: Molecular Insights and Classification. Curr Neurol Neurosci Rep. 2020.

review2020

Medication Comparisons

Compare medications used to treat Yap1 Mamld1 Fusion Positive Supratentorial Ependymoma C5670480. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy